OraDisc™ Consumer Market Research

In excess of 700 patients enrolled in a Phase III clinical study and a 28 day safety study completed a survey questionnaire:

  • Product considered easy to apply.
  • Perceived effectiveness scored highly.
  • Intent to purchase scored highly.

Independent consumer research has confirmed findings of the survey conducted on the clinical study patients.

More about Transmucosal Drug Delivery (OraDisc™)

More about Nanoflex® Technology